STOCK TITAN

Orbis, Allan Gray report 6.3% stake in CRISPR Therapeutics (CRSP)

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

CRISPR Therapeutics reporting persons Orbis Investment Management Ltd and Allan Gray Australia Pty Ltd filed an Amendment No. 2 to a Schedule 13G/A disclosing beneficial ownership. The filing shows 6,106,011 shares beneficially owned in total, representing 6.3% of common stock. Orbis holds 6,090,194 shares with sole voting and dispositive power; Allan Gray holds 15,817 shares with sole voting and dispositive power. The filing states these Reporting Persons are classified as non-U.S. institutions equivalent to an investment adviser and includes a certification regarding foreign regulatory comparability.

Positive

  • None.

Negative

  • None.

Insights

Two non-U.S. investment institutions report a combined 6.3% stake in CRISPR Therapeutics.

Orbis Investment Management Ltd is shown with 6,090,194 shares of sole voting and dispositive power and Allan Gray Australia Pty Ltd with 15,817 shares. The combined beneficial ownership reported is 6,106,011 shares or 6.3%.

The filing is an ownership disclosure under a Schedule 13G/A amendment and includes a statement that the reporting persons are non-U.S. institutions equivalent to an investment adviser; timing and cash‑flow treatment are not described in the excerpt.

The amendment affirms regulatory comparability and provides standard beneficial‑ownership detail.

The filing includes a certification that the foreign regulatory scheme for the Reporting Persons is substantially comparable to the U.S. equivalent and offers to furnish additional information on request. It also disclaims group beneficial ownership between the Reporting Persons.

Documentary responsibilities and potential staff inquiries are the primary compliance implications; no transaction or change-in-control language appears in the excerpt.

Beneficially owned 6,106,011 shares Total beneficial ownership reported in Item 4(a)
Percent of class 6.3% Percent of common stock represented by 6,106,011 shares
Orbis sole voting power 6,090,194 shares Orbis sole power to vote and dispose listed in Item 4(c)(i)/(iii)
Allan Gray sole voting power 15,817 shares Allan Gray sole power to vote and dispose listed in Item 4(c)(i)/(iii)
Schedule 13G/A regulatory
"Amendment No. 2 to a Schedule 13G/A disclosing beneficial ownership"
A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.
beneficially owned financial
"Amount beneficially owned: 6,106,011 (b) Percent of class: 6.3 %"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
sole dispositive power regulatory
"Sole power to dispose or to direct the disposition of: ORBIS - 6,090,194"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





H17182108

(CUSIP Number)
03/31/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



ORBIS INVESTMENT MANAGEMENT LTD
Signature:Matthew Gaarder
Name/Title:Attorney-in-Fact
Date:05/15/2026
Allan Gray Australia Pty Ltd
Signature:Matthew Gaarder
Name/Title:Attorney-in-Fact
Date:05/15/2026

FAQ

What stake does Orbis Investment Management report in CRSP?

Orbis Investment Management Ltd reports 6,090,194 shares with sole voting and dispositive power. This holding is part of the combined 6,106,011 shares disclosed, representing 6.3% of the class.

How many shares does Allan Gray Australia report owning in CRSP?

Allan Gray Australia Pty Ltd reports ownership of 15,817 shares with sole voting and dispositive power, included in the combined total of 6,106,011 shares representing 6.3% of common stock.

Does this filing create a group between the two reporting persons?

No. The filing states that, although the two entities filed together, neither represents it is a member of a group under Section 13(d)(3) and each disclaims beneficial ownership of the other's shares.

What regulatory classification do the reporting persons claim?

Both Orbis and Allan Gray are classified as Non-U.S. Institutions (FI) equivalent to an Investment Adviser (IA). The filing includes a certification of substantial comparability to the U.S. regulatory scheme.

Does the amendment disclose any voting or disposition powers?

Yes. The filing lists specific powers: Orbis has sole voting and sole dispositive power over 6,090,194 shares; Allan Gray has sole voting and dispositive power over 15,817 shares as reported in Item 4.